Philip N Hawkins Selected Research

Gadolinium

1/2020	Noncontrast Magnetic Resonance for the Diagnosis of Cardiac Amyloidosis.
11/2017	Prospective comparison of novel dark blood late gadolinium enhancement with conventional bright blood imaging for the detection of scar.
7/2017	Magnetic Resonance in Transthyretin Cardiac Amyloidosis.
1/2017	A case report in cardiovascular magnetic resonance: the contrast agent matters in amyloid.
3/2016	Response to Letters Regarding Article, "Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis".
10/2015	Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis.
3/2015	Cardiovascular magnetic resonance for amyloidosis.
2/2014	CMR-based differentiation of AL and ATTR cardiac amyloidosis.
9/2013	T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique.
11/2008	Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Philip N Hawkins Research Topics

Disease

136	Amyloidosis 05/2024 - 06/2002
67	Immunoglobulin Light-chain Amyloidosis 01/2024 - 05/2003
31	Amyloid Plaque 12/2022 - 10/2002
25	Cardiomyopathies (Cardiomyopathy) 03/2024 - 03/2004
14	Transthyretin-Related Hereditary Amyloidosis 01/2023 - 06/2005
13	Inflammation (Inflammations) 09/2017 - 02/2004
11	Chronic Kidney Failure (Chronic Renal Failure) 12/2022 - 11/2005
11	Cryopyrin-Associated Periodic Syndromes 01/2021 - 09/2002
9	Proteinuria 01/2020 - 10/2002
8	Renal Insufficiency (Renal Failure) 01/2020 - 03/2004
7	Heart Failure 05/2024 - 12/2022
7	Paraproteinemias (Monoclonal Gammopathy) 01/2023 - 07/2003
7	Familial Amyloidosis (Hereditary Amyloidosis) 05/2017 - 05/2003
6	Polyneuropathies (Polyneuropathy) 03/2024 - 03/2004
6	Aortic Valve Stenosis (Aortic Stenosis) 01/2022 - 04/2013
6	Fever (Fevers) 02/2013 - 09/2002
5	Disease Progression 05/2024 - 06/2013
5	Infections 12/2022 - 01/2009
5	Familial Amyloid Neuropathies (Familial Amyloid Polyneuropathy) 01/2020 - 10/2004
4	Hypertrophy 01/2023 - 03/2015
4	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 04/2006
4	autosomal dominant familial Periodic fever 01/2011 - 01/2002
3	Chronic Renal Insufficiency 11/2023 - 02/2011
3	Body Weight (Weight, Body) 01/2018 - 08/2006
3	Necrosis 12/2012 - 04/2006
2	Bundle-Branch Block (Fascicular Block) 01/2021 - 10/2020
2	Restrictive Cardiomyopathy 01/2020 - 01/2018
2	Schnitzler Syndrome 01/2018 - 02/2013
2	Rare Diseases (Rare Disease) 06/2016 - 09/2013
2	Nephrotic Syndrome (Syndrome, Nephrotic) 06/2014 - 12/2006
2	Cardiovascular Diseases (Cardiovascular Disease) 02/2014 - 04/2006
2	Myocardial Infarction 09/2013 - 04/2006
2	Infarction (Infarctions) 09/2013 - 04/2006
2	Acute-Phase Reaction 10/2012 - 11/2005
2	Heart Diseases (Heart Disease) 10/2012 - 10/2004

Drug/Important Bio-Agent (IBA)

100	Amyloid (Amyloid Fibrils)IBA 03/2024 - 06/2002
64	Prealbumin (Transthyretin)IBA 05/2024 - 06/2002
31	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2003
17	AA amyloidosisIBA 11/2022 - 09/2002
15	Biomarkers (Surrogate Marker)IBA 02/2024 - 10/2012
12	Brain Natriuretic Peptide (Natrecor)FDA Link 05/2024 - 11/2007
11	Serum Amyloid P-ComponentIBA 01/2018 - 11/2002
10	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 01/2022 - 07/2003
10	Bortezomib (Velcade)FDA Link 04/2021 - 02/2008
10	GadoliniumIBA 01/2020 - 11/2008
10	Fibrinogen (Factor I)FDA Link 07/2019 - 06/2002
9	Blood Proteins (Serum Proteins)IBA 12/2021 - 11/2002
8	pro-brain natriuretic peptide (1-76)IBA 03/2024 - 04/2013
8	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2023 - 06/2002
8	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2018 - 02/2004
7	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2023 - 11/2005
6	Troponin T (Troponin T1)IBA 02/2024 - 01/2013
6	C-Reactive ProteinIBA 02/2024 - 11/2005
6	CreatinineIBA 11/2023 - 06/2007
6	canakinumab FDA Link 01/2021 - 06/2009
6	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020 - 01/2007
6	AntibodiesIBA 01/2019 - 11/2005
5	AcidsIBA 01/2022 - 11/2014
5	Interleukin-1 (Interleukin 1)IBA 07/2019 - 02/2004
5	pyrrolidineIBA 01/2018 - 05/2009
5	Carboxylic AcidsIBA 01/2018 - 05/2009
5	DNA (Deoxyribonucleic Acid)IBA 02/2013 - 01/2002
4	patisiranIBA 12/2021 - 08/2013
3	DiureticsIBA 05/2024 - 01/2022
3	TroponinIBA 02/2024 - 11/2007
3	InterleukinsIBA 01/2021 - 12/2006
3	Immunoglobulin M (IgM)IBA 01/2018 - 11/2008
3	Complement System Proteins (Complement)IBA 09/2015 - 04/2006
3	Doxycycline (Periostat)FDA LinkGeneric 01/2015 - 06/2013
3	Thalidomide (Thalomid)FDA Link 09/2014 - 01/2007
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2014 - 01/2007
3	Type I Tumor Necrosis Factor ReceptorsIBA 12/2012 - 01/2002
3	Proline (L-Proline)FDA Link 11/2010 - 05/2009
3	Interleukin-1beta (Interleukin 1 beta)IBA 05/2009 - 06/2006
2	Technetium (Technetium 99m)IBA 02/2024 - 06/2016
2	AlbuminsIBA 11/2023 - 04/2013
2	apolipoprotein A-IV (apolipoprotein AIV)IBA 01/2023 - 11/2021
2	Diflunisal (Dolobid)FDA Link 12/2021 - 01/2015
2	Monoclonal AntibodiesIBA 01/2021 - 05/2012
2	Colchicine FDA LinkGeneric 01/2021 - 11/2007
2	revusiranIBA 12/2020 - 01/2020
2	Lenalidomide (CC 5013)FDA Link 01/2020 - 09/2014
2	Congo RedIBA 01/2019 - 06/2017
2	CytokinesIBA 01/2018 - 01/2011
2	miridesapIBA 01/2018 - 01/2018
2	AntigensIBA 01/2017 - 06/2006
2	ParaproteinsIBA 10/2016 - 02/2006
2	RNA (Ribonucleic Acid)IBA 06/2016 - 05/2012
2	GelsolinIBA 12/2014 - 06/2014

Therapy/Procedure

35	Therapeutics 01/2023 - 11/2002
18	Drug Therapy (Chemotherapy) 01/2023 - 07/2003
7	Stem Cell Transplantation 04/2021 - 02/2006
7	Liver Transplantation 01/2015 - 03/2004
5	Kidney Transplantation 01/2021 - 12/2006
4	Transplantation 12/2022 - 03/2007
4	Lasers (Laser) 05/2017 - 10/2011
3	Transcatheter Aortic Valve Replacement 01/2022 - 01/2018
2	Aftercare (After-Treatment) 01/2024 - 12/2018
2	RNAi Therapeutics 01/2018 - 08/2013
2	Injections 01/2017 - 08/2006